Press releases

 More choices emerge for people living with HIV24 July 2019 (Mexico City, Mexico) – NNew evidence released today at the 10th IAS Conference on HIV Science (IAS 2019) highlights important advancements in antiretroviral therapy, including new and more efficient regimens with the potential to change the treatment landscape. Continue reading

 New vaccine trial and early results from first human trial of PrEP implant revealed23 July 2019 (Mexico City, Mexico) – New studies released at the 10th IAS Conference on HIV Science (IAS 2019) place the spotlight on progress that could completely change the HIV prevention landscape. These include advancements in oral pre-exposure prophylaxis (PrEP) delivery, long-acting implants and vaccines.. Continue reading

New report provides first-time analysis of success across six locations22 July 2019 (Mexico City, Mexico) – For the first time, AIDS experts have brought together new assessments from six locations around the world that have made impressive progress fighting the epidemic, identifying the common contributors to success and providing a roadmap to ending the epidemic globally.Continue reading

22 July 2019 (Mexico City, Mexico) – New evidence presented at the 10th IAS Conference on HIV Science (IAS 2019) offers further analysis from the highly-publicized Evidence for Contraceptive Options and HIV Outcomes (ECHO) trial, which just a few weeks ago finally put to rest the long-standing concern that certain hormonal contraceptives might increase women’s risk of becoming infected with HIV.ECHO was a randomized, open-label clinical trial conducted in four African countries that ...

22 July 2019 (Mexico City, Mexico) – The safety of the HIV treatment drug, dolutegravir (DTG), during pregnancy has been one of the most urgent questions in global health for the past year.At the 22nd International AIDS Conference (AIDS 2018) last year, data from the Tsepamo study in Botswana suggested that the use of DTG in early pregnancy may be linked to neural tube defects (NTDs), serious birth defects of the brain and spine.Continue reading

IAS 2019 opens with a spotlight on humanitarian disaster21 July 2019 (Mexico City, Mexico) – More than 5,000 people from 140 counties have gathered in Mexico City for the opening of the 10th IAS Conference on HIV Science (IAS 2019), where global experts called for urgent action to address the health needs of millions of people affected by humanitarian crises.Experts grappled with the question, “Is the global HIV response in crisis?” They focused on challenges that threaten the ...

21 July 2019 (Mexico City, Mexico) – The International AIDS Society (IAS) announced recipients of prizes and awards at the 10th IAS Conference on HIV Science (IAS 2019) today. These recognize innovation in HIV research, leadership in protecting human rights and the most promising work by an emerging generation of early-career scientists.The honourees will take the stage in Mexico City this week in recognition of their contributions to the field.“We are witnessing an exciting moment i...